{"title":"2010 - 2019年国民健康保险和医疗援助受益人阿尔茨海默病患病率轨迹","authors":"Sanghyun Kim, Changsoo Kim, Yoon Jung Choi","doi":"10.3349/ymj.2024.0303","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Alzheimer's disease (AD) is the leading cause of dementia and is associated with various socioeconomic factors. This study aimed to ascertain the differences in AD prevalence based on healthcare coverage type as a proxy of socioeconomic status in South Korea.</p><p><strong>Materials and methods: </strong>We examined Health Insurance Review and Assessment Service claims from 2010-2019, identifying AD as the main disease. Crude prevalence rate and age- and sex-standardized prevalence were estimated from healthcare utilization data. Subgroup analysis by age, sex, comorbidities (hypertension, diabetes, and cardiovascular disease), and type of healthcare coverage [Medical Aid (MA) vs. National Health Insurance (NHI)] was performed to estimate the standardized prevalence rate ratio (PRR).</p><p><strong>Results: </strong>AD prevalence increased 3.9 times from 2010 (175688 cases) to 2019 (680800 cases). In the NHI group, the standardized prevalence increased 2.3-fold (624.4 in 2010 and 1433.2 in 2019), whereas the MA group saw a 2.7-fold increase (1251.0 in 2010 and 3391.9 in 2019). AD was significantly higher in the MA group from 2010 [PRR=2.00, 95% confidence interval (CI) 1.98-2.03] to 2019 (PRR=2.37, 95% CI 2.35-2.38) compared to the NHI group. From 2010 to 2019, a proportion of comorbidities increased in MA and NHI groups. Compared to the NHI group, the MA group showed significantly higher proportion of comorbidities.</p><p><strong>Conclusion: </strong>In this study, we identified significant differences in AD prevalence between NHI and MA recipients, with a notable increase in the MA group, especially among those under 60 years of age.</p>","PeriodicalId":23765,"journal":{"name":"Yonsei Medical Journal","volume":"66 9","pages":"590-598"},"PeriodicalIF":2.8000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394758/pdf/","citationCount":"0","resultStr":"{\"title\":\"Trajectories of Alzheimer's Disease Prevalence among National Health Insurance and Medical Aid Beneficiaries from 2010 to 2019.\",\"authors\":\"Sanghyun Kim, Changsoo Kim, Yoon Jung Choi\",\"doi\":\"10.3349/ymj.2024.0303\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Alzheimer's disease (AD) is the leading cause of dementia and is associated with various socioeconomic factors. This study aimed to ascertain the differences in AD prevalence based on healthcare coverage type as a proxy of socioeconomic status in South Korea.</p><p><strong>Materials and methods: </strong>We examined Health Insurance Review and Assessment Service claims from 2010-2019, identifying AD as the main disease. Crude prevalence rate and age- and sex-standardized prevalence were estimated from healthcare utilization data. Subgroup analysis by age, sex, comorbidities (hypertension, diabetes, and cardiovascular disease), and type of healthcare coverage [Medical Aid (MA) vs. National Health Insurance (NHI)] was performed to estimate the standardized prevalence rate ratio (PRR).</p><p><strong>Results: </strong>AD prevalence increased 3.9 times from 2010 (175688 cases) to 2019 (680800 cases). In the NHI group, the standardized prevalence increased 2.3-fold (624.4 in 2010 and 1433.2 in 2019), whereas the MA group saw a 2.7-fold increase (1251.0 in 2010 and 3391.9 in 2019). AD was significantly higher in the MA group from 2010 [PRR=2.00, 95% confidence interval (CI) 1.98-2.03] to 2019 (PRR=2.37, 95% CI 2.35-2.38) compared to the NHI group. From 2010 to 2019, a proportion of comorbidities increased in MA and NHI groups. Compared to the NHI group, the MA group showed significantly higher proportion of comorbidities.</p><p><strong>Conclusion: </strong>In this study, we identified significant differences in AD prevalence between NHI and MA recipients, with a notable increase in the MA group, especially among those under 60 years of age.</p>\",\"PeriodicalId\":23765,\"journal\":{\"name\":\"Yonsei Medical Journal\",\"volume\":\"66 9\",\"pages\":\"590-598\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12394758/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Yonsei Medical Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3349/ymj.2024.0303\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yonsei Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3349/ymj.2024.0303","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
目的:阿尔茨海默病(AD)是痴呆症的主要病因,与多种社会经济因素有关。本研究旨在确定基于医疗保险类型的AD患病率差异,作为韩国社会经济地位的代理。材料和方法:我们检查了2010-2019年健康保险审查和评估服务的索赔,确定AD为主要疾病。根据医疗保健利用数据估计粗患病率和年龄和性别标准化患病率。按年龄、性别、合并症(高血压、糖尿病和心血管疾病)和医疗保险类型[医疗援助(MA)与国民健康保险(NHI)]进行亚组分析,以估计标准化患病率比(PRR)。结果:从2010年(175688例)到2019年(680800例),AD患病率增加了3.9倍。在NHI组中,标准化患病率增加了2.3倍(2010年为624.4,2019年为1433.2),而MA组增加了2.7倍(2010年为1251.0,2019年为3391.9)。2010年至2019年,MA组的AD明显高于NHI组[PRR=2.00, 95%可信区间(CI) 1.98-2.03] (PRR=2.37, 95% CI 2.35-2.38)。从2010年到2019年,MA组和NHI组的合并症比例增加。与NHI组相比,MA组的合并症比例明显高于NHI组。结论:在这项研究中,我们发现了NHI和MA接受者之间AD患病率的显著差异,MA组显著增加,特别是在60岁以下的人群中。
Trajectories of Alzheimer's Disease Prevalence among National Health Insurance and Medical Aid Beneficiaries from 2010 to 2019.
Purpose: Alzheimer's disease (AD) is the leading cause of dementia and is associated with various socioeconomic factors. This study aimed to ascertain the differences in AD prevalence based on healthcare coverage type as a proxy of socioeconomic status in South Korea.
Materials and methods: We examined Health Insurance Review and Assessment Service claims from 2010-2019, identifying AD as the main disease. Crude prevalence rate and age- and sex-standardized prevalence were estimated from healthcare utilization data. Subgroup analysis by age, sex, comorbidities (hypertension, diabetes, and cardiovascular disease), and type of healthcare coverage [Medical Aid (MA) vs. National Health Insurance (NHI)] was performed to estimate the standardized prevalence rate ratio (PRR).
Results: AD prevalence increased 3.9 times from 2010 (175688 cases) to 2019 (680800 cases). In the NHI group, the standardized prevalence increased 2.3-fold (624.4 in 2010 and 1433.2 in 2019), whereas the MA group saw a 2.7-fold increase (1251.0 in 2010 and 3391.9 in 2019). AD was significantly higher in the MA group from 2010 [PRR=2.00, 95% confidence interval (CI) 1.98-2.03] to 2019 (PRR=2.37, 95% CI 2.35-2.38) compared to the NHI group. From 2010 to 2019, a proportion of comorbidities increased in MA and NHI groups. Compared to the NHI group, the MA group showed significantly higher proportion of comorbidities.
Conclusion: In this study, we identified significant differences in AD prevalence between NHI and MA recipients, with a notable increase in the MA group, especially among those under 60 years of age.
期刊介绍:
The goal of the Yonsei Medical Journal (YMJ) is to publish high quality manuscripts dedicated to clinical or basic research. Any authors affiliated with an accredited biomedical institution may submit manuscripts of original articles, review articles, case reports, brief communications, and letters to the Editor.